> 数据图表各位网友请教一下3.1 创新药（A）：收入维持快速增长态势，盈利规模效应显著2026-9-23.1 创新药（A）：收入维持快速增长态势，盈利规模效应显著图表21：A股创新药公司经营数据营业收入增速扣非归母净利润增速扣非净利率2024百济神州-U 56.2% 40.5% 26.8% 23.3% 44.4% 126.4% 1017.6% 233.3% -19.8%2026H1 2026Q22024202520252.1%20242026H1 2026Q22026H1 2026Q213.1% 13.1%艾力斯76.3% 45.8% 39.9% 36.1% 124.5% 48.5% 51.0% 44.1% 38.3% 39.0% 41.2% 42.3%百利天恒 936.3% -56.7%-10.6% 547.3% -132.1% -43.6% -38.8% 62.4% -46.3% -901.5% -926.0%三生国健 17.7% 251.8% 34.8% 31.3% 19.0% 1025.0% 65.2% 73.7% 20.6% 65.9% 30.0% 25.5%荣昌生物 58.5% 89.4% 433.1% 808.6% 2.3% 104.5% 1073.8% 2360.6% -87.8%74.1% 84.2%诺诚健华 36.7% 135.3% 55.5% 73.8% 29.7% 225.7% 327.4% 208.7% -43.6% 23.3% 16.5% 15.0%-5.2%44.8% 38.7% -249.8% -105.0% -44.2% -45.3%泽璟制药-U 37.9% 52.1% 220.9% 44.2% 50.9% -15.6% 700.7% 70.1% -32.1% -24.4% 51.1%迪哲医药-U 294.2% 122.6% 47.2% 38.3% 22.6%20253.7%9.4%6.4%石药创新 -20.8%8.9% 208.7% 345.9% -94.3% -795.3% 3079.6%12823.6%2.1%-13.6% 37.8% 51.9%迈威生物-U 56.3% 231.6% 209.0% 228.2% -0.9%6.6%1.3% -535.4% -150.8% -165.8% -149.4%前沿生物-U 13.3%7.7%7.6% 211.8% -47.7% -252.8% -245.0% 41.0% -562.8%-4.7% 434.3% -46.7%益方生物-U -9.0% -77.9% 178.2% -1.8%14.8% -31.5% -11.6% -39.1% -148.2% -881.8% -269.9% -913.8%君实生物-U 29.7% 28.2% 45.2% 45.2% 43.9% 23.3% 57.5% 75.0% -66.2% -39.6% -12.0% -6.2%9.6%资料来源：Wind、中邮证券研究所请参阅附注免责声明17中邮证券健康医疗
